Autres langues Todos Medical Ltd.

Actions

TOMDF

IL0011392375

Marché Fermé - OTC Markets Autres places de cotation 19:07:29 25/04/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	0,00 %		0,00 %	-99,50 %

2023	Todos annonce un avis d'autorisation de l'Uspto pour une demande de brevet couvrant l'utilisation de compositions dans Tollovid ? et Tollovir ? Ingrédients	CI
2023	Todos Medical lance un plan de validation pour le test PCR de l'influenza aviaire A (H5N1, grippe aviaire) au laboratoire de test CLIA/CAP Provista Diagnostics	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Todos Medical Announces Insolvency Proceedings in Israel	22/12
Todos Medical Provides Corporate Update, Retooling to Focus on Long COVID Epidemic	27/09/23
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic	26/09/23
Todos Announces Notice of Allowance from USPTO for Patent Application Covering Use of Compositions in Tollovid and Tollovir Ingredients	31/08/23
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients	30/08/23
Todos Announces Notice of Allowance from Uspto for Patent Application Covering Use of Compositions in Tollovid?? and Tollovir?? Ingredients	30/08/23
CapitalGainsReport: Top Corona Stocks Watchlist (AXLA, BIXT, TOMDF, NVAX, MRNA)	30/08/23
TODOS MEDICAL LTD. : Entry into a Material Definitive Agreement (form 8-K)	31/03/23
Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics	28/03/23
Todos Medical Begins Trading on the OTC Pink Marketplace	27/03/23
Todos Medical Supports Long COVID Awareness Day	15/03/23
Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders	14/03/23
Todos Medical Provides Corporate Update	23/02/23
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics	14/02/23
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics	14/02/23
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference	06/12/22
Todos Medical's 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022	30/11/22
Todos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022	29/11/22
Todos Medical to Attend World Antiviral Congress	22/11/22
Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network	16/11/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Todos Medical Ltd.

Actions

TOMDF

IL0011392375

Autres langues

Filtres